BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/23/2022 10:30:01 AM | Browse: 62 | Download: 104
| Publication Name |
World Journal of Clinical Cases |
| Manuscript ID |
80540 |
| Country/Territory |
China |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Multidisciplinary treatment of a patient with severe immune checkpoint inhibitor-induced colitis: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lu Lu, Li Sha, Yu Feng and Liang Yan |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Shanghai Municipal Health Commission, Shanghai Muricipal Administrator of Traditional Chinese Medicine |
NO. ZY (2021-2023)-0201-02 |
|
| Corresponding Author |
Liang Yan, PhD, Associate Chief Physician, Department of General Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, No. 185 Pu'an Road, Huangpu District, Shanghai 200021, China. yanliang0831@163.com |
| Key Words |
Immune checkpoint inhibitor; Colitis; Programmed cell death ligand 1; Infliximab; Laparoscopic surgery; Case report |
| Core Tip |
Immune checkpoint inhibitors (ICIs) sometimes lead to diarrhea and colitis, which are routinely treated with immunosuppressive therapy. For ICI-related colitis with ineffective medical treatment, timely surgical intervention could prevent the death of patients. |
| Citation |
Lu L, Sha L, Feng Y, Yan L. Multidisciplinary treatment of a patient with severe immune checkpoint inhibitor-induced colitis: A case report. World J Clin Cases 2022; 10(35): 13108-13114 |
 |
Received |
|
2022-10-02 06:26 |
|
Peer-Review Started |
|
2022-10-02 06:27 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-10-21 01:27 |
|
Revised |
|
2022-11-02 06:38 |
|
Second Decision |
|
2022-11-23 03:13 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-11-23 10:30 |
|
Articles in Press |
|
2022-11-23 10:30 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-11-20 12:56 |
|
Typeset the Manuscript |
|
2022-12-02 05:59 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Assistant Editor |
Assistant Editor |
| Science Editor |
Yu-Lu Chen |
| Reviewer Code |
03261497, 06360634, 06271739, and 06303021 |
| Editorial Director |
|
| Journal Chief Editor |
|
| Company Chief Editor |
Jin-Lei Wang |
| Language Editor |
Tian-Qi Wang |
| Production Editor |
Xiang-Di Zhang |
| Responsible Production Editor |
Hua-Ge Yu |
| Responsible Science Editor |
|
| Proofing Editorial Director |
Jin-Lei Wang |
| Proofing Editor-in-Chief |
Lian-Sheng Ma |
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
